Essential pharma

Index
Globenewswire

Essential Pharma and Clinigen Expand Collaboration to Improve Patient Access in JAPAC

Globenewswire

Essential Pharma Announces €900 Million Recapitalisation Through a Gyrus Capital Continuation Vehicle led by AlpInvest and New Strategic Financing from Sixth Street

Globenewswire

Essential Pharma Announces the Acquisition of Reminyl® (galantamine hydrobromide) Oral Capsules

Globenewswire

Essential Pharma Acquires European Rights to Colobreathe®(Colistimethate Codium) from Teva